The important role of ROR1 in cancer prompted early therapeutic investigations, including the development of anti-ROR1 antibodies [19], antibody-drug conjugates (antibody-fused to bacterial toxin) [20], chimeric antigen receptor (CAR) T cell therapy [21,22,23,24], as well as small molecule inhibitors [25]. The gene discussed is ROR1; the disease is cancer.